Skip to main content
TriangleGet started

Phase 1

First-in-human cancer trials, recruiting now.

One page for each Phase 1 cancer study that is open to new patients today: the drug, how the study runs, the papers behind it, and the people running it. Pick a cancer to start.

66 studies · 10 cancers · recruiting now

How these trials work

What is a Phase 1 cancer trial?Common questions

Educational notes, not clinical evidence.

By cancer

  1. Brain and CNS24 studies
  2. Breast1 study
  3. Lung and thoracic7 studies
  4. Leukemia, lymphoma, and myeloma25 studies
  5. Pancreas1 study
  6. Liver and bile duct3 studies
  7. Ovary and gynecologic2 studies
  8. Kidney and bladder1 study
  9. Sarcoma1 study
  10. Neuroblastoma and other childhood tumors1 study

Recent films

Start with a drug.

Short explainers built from the registry record. Each one sits on the trial page with the papers and the people.

  1. TafasitamabLeukemia, lymphoma, and myelomaNon Hodgkin Lymphoma
  2. Neural Stem Cells-expressing CRAd-S-pk7Brain and CNSCurrently Only Enrolling Glioblastoma Patients at First Recurrence
  3. Mesenchymal Stromal Cells-derived Exosomes with KRAS G12D siRNAPancreasMetastatic Pancreatic Adenocarcinoma
  4. G207Brain and CNSNeoplasms, Brain
  5. Cord Blood-derived Expanded Allogeneic Natural Killer CellsBrain and CNSRecurrent Gliosarcoma
  6. CD22CART cellLeukemia, lymphoma, and myelomaHairy Cell Leukemia
  7. B7-H3.CD28Z.CARTBrain and CNSCentral Nervous System Neoplasms
  8. MDC-CAR-BCMA001 (BCMA directed CAR T-cells)Leukemia, lymphoma, and myelomaNeoplasms
Phase 1 — first-in-human trials, explained